Viewing Study NCT01616303


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2025-12-25 @ 4:57 PM
Study NCT ID: NCT01616303
Status: COMPLETED
Last Update Posted: 2020-09-14
First Post: 2012-05-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Sponsor: Quest PharmaTech Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module